The markets advanced during the midday with the Dow soaring 99 points to 17,482 after Republicans won control of Congress. Nasdaq added 7 points to 4,631.
On the upside
Criteo (Nasdaq: CRTO) reported sharply higher third quarter earnings and revenue.
Aeterna Zentaris (Nasdaq: AEZS) fell to a loss for the third quarter but the biopharmaceutical said that sales of EstroGel should begin in a few weeks.
Callidus Software (Nasdaq: CALD) widened third quarter losses but revenue rose to top estimates prompting the company to lift its full year revenue.
On the downside
Nu Skin Enterprises (NYSE: NUS) reported lower third quarter earnings and revenue and forecast current quarter earnings that fell short of analyst expectations.
Albany Molecular Research (Nasdaq: AMRI) fell to an unexpected loss for the third quarter and forecast full year results below estimates.
HomeAway (Nasdaq: AWAY) reported lower third quarter earnings and forecast current quarter revenue that missed expectations.
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 gained 10 points to 2022. Bitcoin climbed $13 to $339.